FDA Adverse Event Injury Summary report: N

GORE® EXCLUDER® AAA ENDOPROSTHESIS

MDR report key: 12874420 · Received November 25, 2021

Report

Report Number
3007284313-2021-01682
Event Type
Injury
Date Received
November 25, 2021
Date of Event
February 2, 2021
Report Date
August 5, 2022
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE PATIENT REFERENCED IN THIS EVENT FILE IS ENROLLED IN A RETROSPECTIVE AND PROSPECTIVE OBSERVATIONAL COHORT REGISTRY DESIGNED TO OBTAIN EARLY DATA ON THE USE OF THE GORE® EXCLUDER® AAA ENDOPROSTHESIS WITH C3 DELIVERY SYSTEM THROUGH THE GLOBAL REGISTRY FOR ENDOVASCULAR AORTIC TREATMENT (GREAT). MEDIDATA RAVE® IS THE CLINICAL STUDY DATABASE (CSD), CAPTURING THE DATA THROUGH THE GRT 10-12 MODULE. THE ABOVE INFORMATION WAS OBTAINED FROM THE CSD. THE SAME PATIENT SHOWED A TYPE III ENDOLEAK. THIS EVENT IS BEING REPORTED ON AN GORE EVENT (B)(4).

Additional Manufacturer Narrative · 0

G1: CORRECTED MANUFACTURING PLANT.

Description of Event or Problem · 0

IT WAS REPORTED THAT ON (B)(6) 2011, THE PATIENT PRESENTED WITH AN ABDOMINAL AORTIC ANEURYSM THAT WAS TREATED WITH GORE® EXCLUDER® AAA ENDOPROSTHESIS. ON (B)(6) 2021, GRAFT INFECTION RELATED TO AN ABSCESS IN THE RIGHT GROIN WAS IDENTIFIED. ON (B)(6) 2021, THE PATIENT WAS HOSPITALIZED, TREATED WITH ANTIBIOTICS, PUNCTURE AND DRAINAGE OF THE ABSCESS. THE PATIENT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1773141 GORE® EXCLUDER® AAA ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES, INC.

Patients

Seq Age Sex Outcome Treatment
1 68 YR Male Required Intervention